Analyst Ratings for Innate Pharma S.A. (IPHA)
IPHA Rating Summary
IPHA Price Target Summary
- Highest: $8.00 (BTIG)
- Lowest: $2.00 (Leerink Partners)
- Average: $5.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$5.75 (+259.4%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
Avg. $ Target:
$5.75 (+259.4%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 84%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/29/2025 | H.C. Wainwright | Swayampakula Ramakanth | Upgrade | Buy (Neutral) |
5.00 (N/A) |
2.09 (1.60) |
-23.44% | Details |
| 10/23/2025 | Lucid Capital Markets | Christopher Liu | New Coverage | Buy (N/A) |
8.00 (N/A) |
2.09 (1.60) |
-23.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
